Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Hayato Yamazaki, Fumio Hirano, Tsutomu Takeuchi, Koichi Amano, Jun Kikuchi, Mari Kihara, Waka Yokoyama, Takahiko Sugihara, Kenji Nagasaka, Hiroyuki Hagiyama, Yoshinori Nonomura, Ryoko Sakai, Michi Tanaka, Ryuji Koike, Toshihiro Nanki, Hitoshi Kohsaka, Nobuyuki Miyasaka & Masayoshi Harigai. (2017) Simplified Disease Activity Index remission at month 6 is an independent predictor of functional and structural remissions at month 12 during abatacept treatment in patients with rheumatoid arthritis: A multi-center, prospective cohort study in Japan. Modern Rheumatology 27:5, pages 787-794.
Read now
Read now
Masayoshi Harigai, Naoki Ishiguro, Shigeko Inokuma, Tsuneyo Mimori, Junnosuke Ryu, Syuji Takei, Tsutomu Takeuchi, Yoshiya Tanaka, Yoshinari Takasaki, Hisashi Yamanaka, Masahiko Watanabe, Hiroshi Tamada & Takao Koike. (2016) Postmarketing surveillance of the safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis. Modern Rheumatology 26:4, pages 491-498.
Read now
Read now
Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ryo Hiroshima, Hiromitsu Takaoka, Kosei Kawakami, Naoko Koenuma, Toshikatsu Shirahata & Shigeki Momohara. (2016) The efficacy of abatacept in Japanese patients with rheumatoid arthritis: 104 weeks radiographic and clinical results in clinical practice. Modern Rheumatology 26:4, pages 499-506.
Read now
Read now
Articles from other publishers (12)
Takanori Azuma, Kenta Misaki, Makio Kusaoi, Yoko Suzuki, Shinji Higa, Yoshitaka Kumon, Tamami Yoshitama, Taio Naniwa, Shinsuke Yamada, Tadashi Okano, Kimihiko Takeuchi, Kei Ikeda, Kenshi Higami, Masayuki Inoo, Tetsuji Sawada, Chonte Kang, Masatoshi Hayashi, Yuko Nagaya, Takafumi Hagiwara, Eisuke Shono, Shinkichi Himeno, Eiichi Tanaka, Eisuke Inoue, Yuri Yoshizawa, Michiaki Kadode, Hisashi Yamanaka & Masayoshi Harigai. (2023)
Influence of concomitant methotrexate use on the clinical effectiveness, retention, and safety of abatacept in biologic-naïve patients with rheumatoid arthritis:
Post-hoc
subgroup analysis of the ORIGAMI study
. Modern Rheumatology 33:2, pages 271-278.
Crossref
Crossref
Naoto Tamura, Takanori Azuma, Kenta Misaki, Rei Yamaguchi, Fuminori Hirano, Eiji Sugiyama, Daisuke Kanai, Yohko Murakawa, Motohiro Oribe, Takahito Kimata, Kazutoshi Aoki, Tomoko Sugiura, Koji Takasugi, Yuya Takakubo, Yasuyuki Tomita, Takeo Isozaki, Toshihiro Nanki, Naooki Katsuyama, Takanori Kuroiwa, Hideto Oshikawa, Motohide Kaneko, Hiroshi Fujinaga, Kiwamu Saito, Eiichi Tanaka, Eisuke Inoue, Yuri Yoshizawa, Shigeru Matsumoto, Hisashi Yamanaka & Masayoshi Harigai. (2022) Effectiveness and safety of subcutaneous abatacept in biologic-naïve RA patients at Week 52: A Japanese multicentre investigational study (ORIGAMI study). Modern Rheumatology 32:5, pages 846-856.
Crossref
Crossref
Lorena Flor da Rosa Franchi Santos, Neide Tomimura Costa, Michael Maes, Andréa Name Colado Simão & Isaias Dichi. (2019) Influence of treatments on cell adhesion molecules in patients with systemic lupus erythematosus and rheumatoid arthritis: a review. Inflammopharmacology 28:2, pages 363-384.
Crossref
Crossref
M. A. Borisova & G. V. Lukina. (2019) Analysis of the use of a selective modulator of cosmulation of T‑lymphocytes abatacept in the treatment of rheumatoid arthritis: data from international clinical practice. Medical alphabet 1:18, pages 13-23.
Crossref
Crossref
Hiroyuki Okada, Hiroshi Kajiya, Yasunori Omata, Takumi Matsumoto, Yuiko Sato, Tami Kobayashi, Satoshi Nakamura, Yosuke Kaneko, Shinya Nakamura, Takuma Koyama, Shunichi Sudo, Masashi Shin, Fujio Okamoto, Hisato Watanabe, Naohiro Tachibana, Jun Hirose, Taku Saito, Toshiyuki Takai, Morio Matsumoto, Masaya Nakamura, Koji Okabe, Takeshi Miyamoto & Sakae Tanaka. (2019) CTLA4‐Ig Directly Inhibits Osteoclastogenesis by Interfering With Intracellular Calcium Oscillations in Bone Marrow Macrophages. Journal of Bone and Mineral Research 34:9, pages 1744-1752.
Crossref
Crossref
Leslie R. Harrold, Bradley S. Stolshek, Sabrina Rebello, David H. Collier, Alex Mutebi, Sally W. Wade, Wendi Malley, Jeffrey D. Greenberg & Carol J. Etzel. (2017) Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry. Clinical Rheumatology 36:4, pages 895-901.
Crossref
Crossref
Sara Monti, Catherine Klersy, Roberto Gorla, Piercarlo Sarzi-Puttini, Fabiola Atzeni, Raffaele Pellerito, Enrico Fusaro, Giuseppe Paolazzi, Pier Andrea Rocchetta, Ennio Giulio Favalli, Antonio Marchesoni & Roberto Caporali. (2017) Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis: real-life data from the Italian LORHEN Registry. Clinical Rheumatology 36:4, pages 753-761.
Crossref
Crossref
Satoshi Kubo, Shingo Nakayamada, Kazuhisa Nakano, Shintaro Hirata, Shunsuke Fukuyo, Ippei Miyagawa, Kentaro Hanami, Kazuyoshi Saito & Yoshiya Tanaka. (2016) Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching. Annals of the Rheumatic Diseases 75:7, pages 1321-1327.
Crossref
Crossref
Alla Ishchenko & Rik J. Lories. (2016) Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance. Drugs & Aging 33:6, pages 387-398.
Crossref
Crossref
Michael Schiff. (2015) Co-stimulation Therapy in Rheumatoid Arthritis: Today and Tomorrow. Current Treatment Options in Rheumatology 1:4, pages 334-349.
Crossref
Crossref
. (2015) Abatacept. Reactions Weekly 1559:1, pages 14-14.
Crossref
Crossref
Krista G. Haanstra, Karin Dijkman, Noun Bashir, Jan Bauer, Caroline Mary, Nicolas Poirier, Paul Baker, Linda Scobie, Bert A. ’t Hart & Bernard Vanhove. (2015) Selective Blockade of CD28-Mediated T Cell Costimulation Protects Rhesus Monkeys against Acute Fatal Experimental Autoimmune Encephalomyelitis. The Journal of Immunology 194:4, pages 1454-1466.
Crossref
Crossref